口蹄疫重组鸡痘病毒活载体疫苗在豚鼠、猪体内的毒性、分布及抗体消长规律

Distribution,virulence and antibody variation of recombinant fowlpox virus vUTAL3CP in cavia cobaya and swine

利用临床观察、病理解剖、PCR、RT-PCR、ELISA、中和抗体检测等方法,对口蹄疫(FMD)重组鸡痘病毒(FPV)在豚鼠、仔猪体内的毒性、分布以及抗体消长规律进行研究。结果表明,FMD重组鸡痘病毒免疫的动物在整个试验期间,未表现出明显的临床症状和不良反应;病理组织切片检测无明显的组织学变化;PCR、RT-PCR检测证明,豚鼠、猪免疫FMD重组鸡痘病毒后,在心脏、肝脏、脾脏、肺脏、肾脏、肌肉、脑、肠系膜淋巴结内检测到FPVDNA和FMDV DNA,且在大部分组织能存在3 d左右;FMD重组鸡痘病毒均可诱导免疫动物产生较高水平的抗FMDV特异性抗体和中和抗体,验证了所构建重组FPV的生物安全性及良好的免疫原性,为其他哺乳动物实验提供了必要的基础数据。

The clinical, histological, viral culture, PCR, neutralizing antibody were used to assess the bio-safety and immunogenicity of the recombinant fowlpox virus. During the experiment, no detectable pathological changes were found in the organs of inoculated cavia cobaya and swine. Using PCR, the viral nucleic acids was detected at 3 days post inoculation （DPI）, viral nucleic acids were found in all organs; none viral nucleic acids were detected from any organs at 10 DPI. In addition, well immunogenicity had been ensured by its ability to induce humoral responses.